Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2026-01-17 @ 7:13 AM
Study NCT ID:
NCT03874858
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-23
First Post:
2019-03-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Full Treatment-free Remission in Patients With Chronic Myeloid Leukemia
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Myeloid Leukemia | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Chronic Myeloid Leukemia (CML) | View |
| None | Chronic Myeloid Leukemia - Chronic Phase (CML-CP) | View |
| None | Deep Molecular Response (DMR) | View |
| None | sustained deep molecular response (sustained DMR) | View |
| None | Treatment-Free Remission (TFR) | View |
| None | Treatment-Free Remission failure (TFR failure) | View |
| None | Full Treatment-Free Remission (FTFR) | View |
| None | Tyrosine Kinase Inhibitor (TKI) | View |
| None | quantitative Polymerase Chain Reaction (qPCR) | View |
| None | digital droplet Polymerase Chain Reaction (ddPCR) | View |
| None | ABL001 (Asciminib) | View |
| None | AMN107 (Nilotinib) | View |
| None | Tasigna | View |
| None | adult | View |